Abstract
Telomeric DNA protects chromosome ends from recombination events and its length serves as a mitotic clock that triggers exit from the cell cycle when telomeres become too short. Telomerase is the enzyme involved in telomere elongation, one of the events that permits unlimited cell proliferation. Variations in telomerase activity were quantified in hematopoietic cell lines after gamma-irradiation. Telomerase activity increased after irradiation of between 0 and 3 Gy in a dose-dependent manner, reaching a maximum at 3 Gy. The increase in telomerase activity was nearly maximum 8 h after irradiation, the peak being observed at around 24 h. Although this kinetics partly correlated with cell redistribution into the G2/M phase of the cell cycle, telomerase activity did not show significant variation over the cell cycle. Therefore, the activation of telomerase observed after gamma-irradiation may suggest the involvement of telomerase in DNA repair and chromosome healing.
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Leteurtre, F., Li, X., Gluckman, E. et al. Telomerase activity during the cell cycle and in gamma-irradiated hematopoietic cells. Leukemia 11, 1681–1689 (1997). https://doi.org/10.1038/sj.leu.2400784
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2400784
- Springer Nature Limited
Keywords
This article is cited by
-
The relationship between longer leukocyte telomeres and dNCR in non-cardiac surgery patients: a retrospective analysis
BMC Anesthesiology (2023)
-
Targeting telomeres: advances in telomere maintenance mechanism-specific cancer therapies
Nature Reviews Cancer (2022)
-
Changes in telomere length distribution in low-dose X-ray-irradiated human umbilical vein endothelial cells
Molecular and Cellular Biochemistry (2014)
-
Telomere Profiling: Toward Glioblastoma Personalized Medicine
Molecular Neurobiology (2013)
-
Irradiation-induced telomerase activity and gastric cancer risk: a case-control analysis in a Chinese Han population
BMC Cancer (2010)